Learning and knowledge sharing are fundamental to the LHSS Project. We invite you to search LHSS knowledge products and resources for the latest approaches, insights, and learning in the field of integrated health systems strengthening.
The 8th Global Symposium on Health Systems Research (HSR 2024) will be held in Nagasaki, Japan, from November 18 to 22, 2024.
LHSS is presenting at the Global Digital Health Forum, December 4-6, 2023, in Washington, DC.
This brief includes a global evidence review of DFS for health conducted by LHSS and an analysis of two programmatic case studies of DFS for health by Management Sciences for Health (MSH) through the Digital Square initiative.
An estimated 170,000 people contract TB each year in Vietnam. The new e-LMIS system helps ensure a reliable drug supply for those who need treatment.
This Catalog allows practitioners to consider which interventions have more robust evidence bases to support their practical application, such as: enhancing worker and supervisor competencies through training, offering nonfinancial incentives for high performers, practicing task sharing to promote cost savings, implementing digital solutions to expand access to services, and reducing costs of procuring and distributing pharmaceutical products.
This Question-and-Answer (Q&A) document covers commonly asked questions and answers on TB exams, treatment, and reimbursement through Social Health Insurance (SHI). It provides guidance to TB treatment facilities as they integrate SHI and transition TB treatment services into SHI. The document also includes hyperlinks as additional reference sources for readers.
LHSS is proud to present at the Global Digital Health Forum, December 5-7, 2022, in Arlington, Virginia.
The Vietnam government transitions funding of TB treatment to the SHI fund with support from LHSS. This transition marks a critical milestone, ensuring uninterrupted access to life-saving treatment.
Vietnam is one of the 30 countries with the highest burden of TB and drug-resistant TB in the world, with more than 172,000 cases and 10,400 deaths from TB in Vietnam in 2020 (WHO). On July 1, TB treatment facilities nationwide started providing TB drugs to patients through social health insurance, marking an important milestone for financial sustainability.
This rapid assessment aimed to determine which health facilities in seven high-TB burden provinces of Vietnam meet social health insurance (SHI) requirements for TB service provision and for reimbursement of TB services through the SHI scheme.
This brief explores ways in which digital tools and systems can be used successfully and responsibly to advance SBC interventions in support of health system strengthening, and provides recommendations for future programming and areas of research.
Lhss prepared this report, discussing procurement and payment considerations related to the transition of first-line tuberculosis (TB) drug procurement in Vietnam from the central state budget to the social health insurance fund starting in 2022.
This document provides a roadmap for Vietnam’s National Tuberculosis (TB) Program to transition procurement and payment for TB drugs to the country’s social health insurance scheme.
For the first time, Vietnam has procured TB medicines using its national social health insurance scheme.
This video captures a November 6, 2020 ceremony in Hanoi which marked the formal start of the LHSS Project’s four-year effort to help the Government of Vietnam implement its social health insurance program. The program covers treatment services for people with HIV, among other essential health services.
Working closely with the Vietnam Social Security (VSS) agency, LHSS will help improve the agency’s capacity to manage the insurance program funds effectively, efficiently, equitably, and with accountability. LHSS will also support Vietnam’s transition to full financial ownership of its HIV and TB responses.